Genetic and clinical study of myeloperoxidase's association with coronary artery disease
Abstract Background Unraveling myeloperoxidase’s (MPO) correlation with coronary artery disease (CAD) and genetic variations, this study seeks to enhance diagnostic precision and therapeutic strategies. Results CAD patients were found to be older and more male than controls. Several clinical parameters, including glucose, total bilirubin, alkaline phosphatase, creatinine, and troponin levels, showed significant variations. Moreover, CAD patients had lower red cell distribution width (RDW%) and mean platelet volume (MPV) than controls. Serum MPO levels did not differ significantly between CAD patients and controls, and no correlation was found with other clinical parameters except for glucose, creatinine, and total bilirubin. Conclusions The data suggest that serum MPO levels are not substantially related to CAD patients, as indicated by lower MPO levels in CAD patients compared to controls. While highlighting the potential of MPV and RDW% as predictors of severe atherosclerosis in CAD. Further research is needed to validate the diagnostic and prognostic value of RDW%, MPV, and MPO levels in CAD. Trial registration: 15092021-9-12. Registered 15 September 2021..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:76 |
|---|---|
| Enthalten in: |
The Egyptian Heart Journal - 76(2024), 1, Seite 10 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Lina N. Adam [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
Biomarkers |
|---|
| doi: |
10.1186/s43044-024-00457-7 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ091190959 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ091190959 | ||
| 003 | DE-627 | ||
| 005 | 20240414051801.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240412s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s43044-024-00457-7 |2 doi | |
| 035 | |a (DE-627)DOAJ091190959 | ||
| 035 | |a (DE-599)DOAJ8ab1f9b15109466794dd42864c5a9532 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 050 | 0 | |a RC666-701 | |
| 100 | 0 | |a Lina N. Adam |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Genetic and clinical study of myeloperoxidase's association with coronary artery disease |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Abstract Background Unraveling myeloperoxidase’s (MPO) correlation with coronary artery disease (CAD) and genetic variations, this study seeks to enhance diagnostic precision and therapeutic strategies. Results CAD patients were found to be older and more male than controls. Several clinical parameters, including glucose, total bilirubin, alkaline phosphatase, creatinine, and troponin levels, showed significant variations. Moreover, CAD patients had lower red cell distribution width (RDW%) and mean platelet volume (MPV) than controls. Serum MPO levels did not differ significantly between CAD patients and controls, and no correlation was found with other clinical parameters except for glucose, creatinine, and total bilirubin. Conclusions The data suggest that serum MPO levels are not substantially related to CAD patients, as indicated by lower MPO levels in CAD patients compared to controls. While highlighting the potential of MPV and RDW% as predictors of severe atherosclerosis in CAD. Further research is needed to validate the diagnostic and prognostic value of RDW%, MPV, and MPO levels in CAD. Trial registration: 15092021-9-12. Registered 15 September 2021. | ||
| 650 | 4 | |a Myeloperoxidase (MPO) | |
| 650 | 4 | |a Coronary artery disease (CAD) | |
| 650 | 4 | |a Biomarkers | |
| 650 | 4 | |a Cardiovascular risk | |
| 650 | 4 | |a Genetic variation | |
| 653 | 0 | |a Diseases of the circulatory (Cardiovascular) system | |
| 700 | 0 | |a Omar A. M. Al-Habib |e verfasserin |4 aut | |
| 700 | 0 | |a Ashur Y. Oraha |e verfasserin |4 aut | |
| 700 | 0 | |a Mudhir S. Shekha |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t The Egyptian Heart Journal |d SpringerOpen, 2016 |g 76(2024), 1, Seite 10 |w (DE-627)DOAJ000044377 |x 2090911X |7 nnns |
| 773 | 1 | 8 | |g volume:76 |g year:2024 |g number:1 |g pages:10 |
| 856 | 4 | 0 | |u https://doi.org/10.1186/s43044-024-00457-7 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/8ab1f9b15109466794dd42864c5a9532 |z kostenfrei |
| 856 | 4 | 0 | |u https://doi.org/10.1186/s43044-024-00457-7 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2090-911X |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 76 |j 2024 |e 1 |h 10 | ||